A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma

Zhangying Feng, Jinglin Gao, Xiaonan Gao, Li Hua, Xuyang Nie, Yaqi Sun, Mingxia Wang Department of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Mingxia WangDepartment of Clinical Pharmacology, The Fourth Hospital of H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Feng Z, Gao J, Gao X, Hua L, Nie X, Sun Y, Wang M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/1386c6abf7c14151b50544850e4d237a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1386c6abf7c14151b50544850e4d237a
record_format dspace
spelling oai:doaj.org-article:1386c6abf7c14151b50544850e4d237a2021-11-07T18:42:56ZA Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma1177-8881https://doaj.org/article/1386c6abf7c14151b50544850e4d237a2021-11-01T00:00:00Zhttps://www.dovepress.com/a-validated-hplc-msms-method-for-quantification-of-methotrexate-and-ap-peer-reviewed-fulltext-article-DDDThttps://doaj.org/toc/1177-8881Zhangying Feng, Jinglin Gao, Xiaonan Gao, Li Hua, Xuyang Nie, Yaqi Sun, Mingxia Wang Department of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Mingxia WangDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, People’s Republic of ChinaTel +86311-66696233Email mxia_wang@163.comPurpose: A simple, rapid and reliable method to quantify methotrexate (MTX) in human plasma by high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) was established and validated in two laboratories.Patients and Methods: Sample separation was achieved on a Synergi Hydro-RP column (50 mm× 2.0 mm, 2.5 μm) with a gradient elution program in 3.5 min after a simple protein precipitation with methanol (MeOH) and acetonitrile (ACN) (1:1). About 5 mM ammonium formate aqueous solution with 0.2% formic acid and ACN were used as mobile phase with a flow rate of 0.5 mL/min at 40 °C. Mass spectrometry detection using AB Sciex Triple Quad 4500 mass spectrometer (4500 QQQ) and Qtrap 5500 mass spectrometer (5500 Q-trap) were both characterized by electrospray ionization (ESI) for positive ions in multiple reaction-monitoring (MRM) mode. Quantitative ion pairs were m/z 455.1→m/z 308.0 for MTX and m/z 248.1→m/z 121.0 for tinidazole (TNZ) used as internal standard (IS).Results: Linear calibration curves were generated over the range of 5– 1000 ng/mL (r2> 0.99) on both the 4500 QQQ and 5500 Q-trap, both of the intra- and inter-batch precision were less than 7.67% and accuracy ranged from 96.33% to 108.94%. The recovery and matrix effect were 82.20– 93.98% and 102.69– 105.28%, respectively.Conclusion: An analytical method transfer was achieved by re-verification in two laboratories to ensure stability and reproducibility and this method has been applied for therapeutic drug monitoring (TDM) successfully in children and adults with NHL, and during routine TDM, two delayed elimination of MTX cases were observed and analyzed.Keywords: methotrexate, therapeutic drug monitoring, non-Hodgkin lymphoma, children, adultFeng ZGao JGao XHua LNie XSun YWang MDove Medical Pressarticlemethotrexatetherapeutic drug monitoringnon-hodgkin lymphomachildrenadultTherapeutics. PharmacologyRM1-950ENDrug Design, Development and Therapy, Vol Volume 15, Pp 4575-4583 (2021)
institution DOAJ
collection DOAJ
language EN
topic methotrexate
therapeutic drug monitoring
non-hodgkin lymphoma
children
adult
Therapeutics. Pharmacology
RM1-950
spellingShingle methotrexate
therapeutic drug monitoring
non-hodgkin lymphoma
children
adult
Therapeutics. Pharmacology
RM1-950
Feng Z
Gao J
Gao X
Hua L
Nie X
Sun Y
Wang M
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
description Zhangying Feng, Jinglin Gao, Xiaonan Gao, Li Hua, Xuyang Nie, Yaqi Sun, Mingxia Wang Department of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of ChinaCorrespondence: Mingxia WangDepartment of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang, 050011, People’s Republic of ChinaTel +86311-66696233Email mxia_wang@163.comPurpose: A simple, rapid and reliable method to quantify methotrexate (MTX) in human plasma by high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) was established and validated in two laboratories.Patients and Methods: Sample separation was achieved on a Synergi Hydro-RP column (50 mm× 2.0 mm, 2.5 μm) with a gradient elution program in 3.5 min after a simple protein precipitation with methanol (MeOH) and acetonitrile (ACN) (1:1). About 5 mM ammonium formate aqueous solution with 0.2% formic acid and ACN were used as mobile phase with a flow rate of 0.5 mL/min at 40 °C. Mass spectrometry detection using AB Sciex Triple Quad 4500 mass spectrometer (4500 QQQ) and Qtrap 5500 mass spectrometer (5500 Q-trap) were both characterized by electrospray ionization (ESI) for positive ions in multiple reaction-monitoring (MRM) mode. Quantitative ion pairs were m/z 455.1→m/z 308.0 for MTX and m/z 248.1→m/z 121.0 for tinidazole (TNZ) used as internal standard (IS).Results: Linear calibration curves were generated over the range of 5– 1000 ng/mL (r2> 0.99) on both the 4500 QQQ and 5500 Q-trap, both of the intra- and inter-batch precision were less than 7.67% and accuracy ranged from 96.33% to 108.94%. The recovery and matrix effect were 82.20– 93.98% and 102.69– 105.28%, respectively.Conclusion: An analytical method transfer was achieved by re-verification in two laboratories to ensure stability and reproducibility and this method has been applied for therapeutic drug monitoring (TDM) successfully in children and adults with NHL, and during routine TDM, two delayed elimination of MTX cases were observed and analyzed.Keywords: methotrexate, therapeutic drug monitoring, non-Hodgkin lymphoma, children, adult
format article
author Feng Z
Gao J
Gao X
Hua L
Nie X
Sun Y
Wang M
author_facet Feng Z
Gao J
Gao X
Hua L
Nie X
Sun Y
Wang M
author_sort Feng Z
title A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
title_short A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
title_full A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
title_fullStr A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
title_full_unstemmed A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
title_sort validated hplc-ms/ms method for quantification of methotrexate and application for therapeutic drug monitoring in children and adults with non-hodgkin lymphoma
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/1386c6abf7c14151b50544850e4d237a
work_keys_str_mv AT fengz avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT gaoj avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT gaox avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT hual avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT niex avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT suny avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT wangm avalidatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT fengz validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT gaoj validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT gaox validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT hual validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT niex validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT suny validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
AT wangm validatedhplcmsmsmethodforquantificationofmethotrexateandapplicationfortherapeuticdrugmonitoringinchildrenandadultswithnonhodgkinlymphoma
_version_ 1718443256907300864